Epax Receive the Frost & Sullivan Award For Product Differentiation Excellence
Epax has received the Frost & Sullivan Product Differentiation Excellence Award. The award recognizes Epax’s condition-specific range of concentrated EPA/DHA omega-3 ingredient products and the company’s success in carving out a niche in a crowded market.
“Product differentiation is one of the prime factors that define success in the omega-3 market,” says Frost & Sullivan Research Analyst, Ashwin Raj Ravinder. “Epax abides by the strictest norms, right from choosing the raw material to final delivery, and they consistently deliver products with the best purity profile in the industry.”
The Epax product range contains an optimum EPA and DHA ratio that offers a cost-effective solution. Multiple clinical studies and the European Food Safety Authority (EFSA) approved health claims strengthen Epax’s marketability and presence.
“Consumers prefer health food and beverages that correspond to their specific ailments. Epax offers a comprehensive product range in the Omega-3 space that tackles condition-specific health concerns unlike other participants in the omega-3 category,” he adds.
Epax also received Frost & Sullivan’s Excellence in Product Quality Award in 2008, which demonstrates that Epax’ purity beyond expectation concept has consistently created value for customers for years. Epax’ customers have valuable brand equity at stake and depend on the highest quality ingredients. Epax delivers on this expectation by living Purity, Quality, Innovation™ every day.
“Epax is honored to be recognized by Frost & Sullivan for our commitment to ultra-pure and high quality condition-specific omega-3 ingredients,” says Ola Snøve, CEO of Epax. “Epax has invested significantly in new and innovative technologies and processes during the last two years and it is truly inspiring to receive this award as we are preparing together with our customers for the launch of our next generation products over the coming year.”
Epax is a 50/50 joint venture between Aker BioMarine and Lindsay Goldberg. Epax is the world leader in marine-derived omega-3 fatty acid concentrates. The company offers a wide range of high quality omega-3 concentrates in the nutraceutical business-to-business segment, as well as pharmaceutical intermediates and active pharmaceutical ingredients (API). The Epax group is headquartered in Oslo, Norway, with cGMP manufacturing facilities in Alesund, Norway and Seal Sands, UK.
